Clincosm LogoSign in Get a demo

aplastic anemia

Showing 1 - 25 of 111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ATGAM General Investigation

Not yet recruiting
  • Aplastic Anemia
  • Anti-human thymocyte immunoglobulin, equine
  • (no location specified)
Sep 8, 2023

Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

Recruiting
  • Aplastic Anemia
  • +2 more
  • Beijing, China
    Peking union medical college hospital
Aug 20, 2023

Aplastic Anemia, Drug Effect Trial in Beijing (Herombopag + CsA, rhTPO combined with Herombopag + CsA)

Not yet recruiting
  • Aplastic Anemia
  • Drug Effect
  • Herombopag + CsA
  • rhTPO combined with Herombopag + CsA
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)

Not yet recruiting
  • Aplastic Anemia
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Health Promotion and Education
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 24, 2023

Aplastic Anemia, Platelet Transfusion Refractoriness Trial in Tianjin (Daratumumab)

Recruiting
  • Aplastic Anemia
  • Platelet Transfusion Refractoriness
  • Tianjin, Tianjin, China
    Regenerative Medicine Center
Apr 25, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 23, 2023

Aplastic Anemia Trial in Worldwide (Eltrombopag, hATG, CsA)

Active, not recruiting
  • Aplastic Anemia
  • Phoenix, Arizona
  • +19 more
Jan 19, 2023

Aplastic Anemia Trial in Tianjin (Avatrombopag 20 MG Oral Tablet)

Recruiting
  • Aplastic Anemia
  • Avatrombopag 20 MG Oral Tablet
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Oct 4, 2022

Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)

Recruiting
  • Aplastic Anemia
  • Bone Marrow Failure Syndrome
  • Anti-Thymocyte Globulin (Rabbit)
  • +8 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 26, 2022

Aplastic Anemia Trial in Suzhou (CD20 mAb, ATG)

Recruiting
  • Aplastic Anemia
  • CD20 monoclonal antibody
  • ATG
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 21, 2022

s of AMG531 (Romiplostim) in Untreated Aplastic Anemia

Enrolling by invitation
  • Aplastic Anemia
    • Kanazawa, Ishikawa Prefecture, Japan
      Kanazawa University, College of Medical Pharmaceutical and Healt
    Aug 18, 2022

    Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)

    Recruiting
    • Aplastic Anemia
    • Expanded autologous T regulatory cells
    • London, United Kingdom
      King's College Hospital
    Aug 16, 2022

    Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)

    Recruiting
    • Acute Leukemia
    • +9 more
    • Total Body Irradiation 1200 cGy
    • +7 more
    • Rochester, New York
      Wilmot Cancer Institute
    Jun 20, 2022

    Aplastic Anemia Trial in Beijing (Luspatercept)

    Not yet recruiting
    • Aplastic Anemia
    • Beijing, China
      Peking union medical college hospital
    May 30, 2022

    Aplastic Anemia Trial in Shinagawa (Romiplostim)

    Completed
    • Aplastic Anemia
    • Shinagawa, Tokyo, Japan
      NTT Medical center Tokyo
    May 25, 2022

    Aplastic Anemia Trial in Nagoya, Shimotsuke, Shinjuku-ku (PF-06462700)

    Completed
    Has Results
    • Aplastic Anemia
    • PF-06462700
    • Nagoya, Aichi, Japan
    • +2 more
    Apr 1, 2022

    Evaluate Safety and Effectiveness of Hetrombopag in ITP or AA

    Not yet recruiting
    • Primary Immune Thrombocytopenia
    • Aplastic Anemia
    • Wuhan, Hubei, China
      Union Hospital, Tongji Medical College, Huazhong University of S
    Apr 11, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Hematopoietic Cell Transplantation
    • +7 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Apr 1, 2022

    Aplastic Anemia, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Ibrutinib)

    Active, not recruiting
    • Aplastic Anemia
    • +6 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Feb 24, 2022

    Aplastic Anemia Trial in Kanazawa, Tokyo, Seoul (Romiplostim)

    Completed
    • Aplastic Anemia
    • Romiplostim
    • Kanazawa, Japan
    • +2 more
    Feb 4, 2022

    National Longitudinal Cohort of Hematological Diseases

    Recruiting
    • Multiple Myeloma
    • +17 more
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Jan 11, 2022

      Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,

      Recruiting
      • Aplastic Anemia
      • +3 more
      • Anti-Thymocyte Globulin
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 1, 2021

      Aplastic Anemia Trial in Worldwide (rabbit antithymocyte globulin)

      Completed
      Has Results
      • Aplastic Anemia
      • rabbit antithymocyte globulin
      • Creteil, France
      • +13 more
      Sep 21, 2021